BrightPath Biotherapeutics Co.Ltd. Financial Overview
BrightPath Biotherapeutics Co.Ltd.'s market cap is currently ¥5.24B. The company's EPS TTM is ¥-1.94; its P/E ratio is -4.15; BrightPath Biotherapeutics Co.Ltd. is scheduled to report earnings on November 14, 2025, and the estimated EPS forecast is ¥―. See an overview of income statement, balance sheet, and cash flow financials.
